Skip to Main content Skip to Navigation
Journal articles

A preclinical mouse model of glioma with an alternative mechanism of telomere maintenance (ALT)

Abstract : Glioblastoma multiforme is the most aggressive primary tumor of the central nervous system. Glioma stem cells (GSCs), a small population of tumor cells with stem-like properties, are supposedly responsible for glioblastoma multiforme relapse after current therapies. In approximately thirty percent of glioblastoma multiforme tumors, telomeres are not maintained by telomerase but through an alternative mechanism, termed alternative lengthening of telomere (ALT), suggesting potential interest in developing specific therapeutic strategies. However, no preclinical model of ALT glioma was available until the isolation of TG20 cells from a human ALT glioma. Herein, we show that TG20 cells exhibit a high level of telomeric recombination but a stable karyotype, indicating that their telomeres retain their protective function against chromosomal instability. TG20 cells possess all of the characteristic features of GSCs: the expression of neural stem cell markers, the generation of intrace-rebral tumors in NOD-SCID-IL2Rc (NSG) mice as well as in nude mice, and the ability to sustain serial intracerebral transplan-tations without expressing telomerase, demonstrating the stability of the ALT phenotype in vivo. Furthermore, we also demonstrate that 360B, a G-quadruplex ligand of the pyridine derivative series that impairs telomere replication and mitotic progression in cancer cells, prevents the development of TG20 tumors. Together, our results show that intracerebral grafts of TG20 cells in immunodeficient mice constitute an efficient preclinical model of ALT glioblastoma multiforme and that G-quadruplex ligands are a potential therapy for this specific type of tumor.
Complete list of metadatas

Cited literature [44 references]  Display  Hide  Download

https://hal.sorbonne-universite.fr/hal-01143394
Contributor : Administrateur Hal-Upmc <>
Submitted on : Friday, April 17, 2015 - 2:44:09 PM
Last modification on : Friday, October 23, 2020 - 9:16:02 AM
Long-term archiving on: : Monday, September 14, 2015 - 10:16:57 AM

File

Jeitany_2015_A_preclinical_mou...
Publication funded by an institution

Licence


Distributed under a Creative Commons Attribution - NonCommercial 4.0 International License

Identifiers

Citation

Maya Jeitany, Jose Ramon Pineda, Quingyuan Liu, Rosa Maria Porreca, Françoise Hoffschir, et al.. A preclinical mouse model of glioma with an alternative mechanism of telomere maintenance (ALT). International Journal of Cancer, Wiley, 2015, 136 (7), pp.1546-1558. ⟨10.1002/ijc.29171⟩. ⟨hal-01143394⟩

Share

Metrics

Record views

2552

Files downloads

1350